Zobrazeno 1 - 10
of 956
pro vyhledávání: '"James B, Young"'
Autor:
Mina K. Chung, Sadashiva Karnik, Joshua Saef, Cornelia Bergmann, John Barnard, Michael M. Lederman, John Tilton, Feixiong Cheng, Clifford V. Harding, James B. Young, Neil Mehta, Scott J. Cameron, Keith R. McCrae, Alvin H. Schmaier, Jonathan D. Smith, Ankur Kalra, Surafel K. Gebreselassie, George Thomas, Edward S. Hawkins, Lars G. Svensson
Publikováno v:
EBioMedicine, Vol 58, Iss , Pp 102907- (2020)
Background: SARS-CoV-2 enters cells by binding of its spike protein to angiotensin-converting enzyme 2 (ACE2). Angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) have been reported to increase ACE2 expression
Externí odkaz:
https://doaj.org/article/354cf01c8d2f4c0f915063b3789d93a1
Autor:
Andrew Xanthopoulos, Konstantinos Tryposkiadis, Filippos Triposkiadis, Kiyotaka Fukamachi, Edward G. Soltesz, James B. Young, Kathy Wolski, Eugene H. Blackstone, Randall C. Starling
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 14 (2020)
Background Left ventricular assist device (LVAD) thrombosis is clinically devastating and impacts the cost effectiveness of LVAD therapy for advanced heart failure. Anticoagulation and antiplatelet therapies represent the standard of care to mitigate
Externí odkaz:
https://doaj.org/article/cd0e9c216a304f2784340e353f93088b
Autor:
Katherine C. Michelis, Lin Zhong, Matthias Peltz, Ambarish Pandey, W. H. Wilson Tang, Anand Rohatgi, James B. Young, Mark H. Drazner, Justin L. Grodin
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 14 (2020)
Background Left ventricular assist devices (LVADs) improve outcomes in patients with end‐stage heart failure and are increasingly implanted for destination therapy. We describe dynamic estimates of event‐free survival with conditional survival pr
Externí odkaz:
https://doaj.org/article/a3b38e1f3cd446cdbf9ada5d27ea4886
Autor:
Lara Jehi, Xinge Ji, Alex Milinovich, Serpil Erzurum, Amy Merlino, Steve Gordon, James B Young, Michael W Kattan
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237419 (2020)
BackgroundCoronavirus Disease 2019 is a pandemic that is straining healthcare resources, mainly hospital beds. Multiple risk factors of disease progression requiring hospitalization have been identified, but medical decision-making remains complex.Ob
Externí odkaz:
https://doaj.org/article/9433b20f37ad496685949e9bd655b9cd
Autor:
James B. Young, Marjolaine Gauthier-Loiselle, Robert A. Bailey, Ameur M. Manceur, Patrick Lefebvre, Morris Greenberg, Marie-Hélène Lafeuille, Mei Sheng Duh, Brahim Bookhart, Carol H. Wysham
Publikováno v:
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-13 (2018)
Abstract Background There exist several predictive risk models for cardiovascular disease (CVD), including some developed specifically for patients with type 2 diabetes mellitus (T2DM). However, the models developed for a diabetic population are base
Externí odkaz:
https://doaj.org/article/55ed74f1c71d4ab1b24e4da0012d6aa9
Publikováno v:
ACS Macro Letters. 11:1390-1395
Controlled radical polymerization techniques enable the synthesis of polymers with predetermined molecular weights, narrow molecular weight distributions, and controlled architectures. Moreover, these polymerization approaches have been routinely sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9aea4d5ac2fb9373ae7b46742b73b87
https://doi.org/10.1021/acsmacrolett.2c00603
https://doi.org/10.1021/acsmacrolett.2c00603
Autor:
James B. Young
Publikováno v:
Methodist DeBakey Cardiovascular Journal. 19:111-113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3555ceb0a81d39579114f0f647c6ac95
https://doi.org/10.14797/mdcvj.1236
https://doi.org/10.14797/mdcvj.1236
Autor:
Christopher D. Anderson, Joshua O. Ikuemonisan, James B. Young, John Rickard, Xiaoxiao Lu, Stelios I Tsintzos, Dedra H. Fagan, Eugene S. Chung, Michael R. Gold, Cecilia Linde, William T. Abraham
Publikováno v:
Heart Rhythm. 19:595-603
Cardiac resynchronization therapy (CRT) reduces mortality and improves outcomes in appropriately selected patients with heart failure (HF); however, response may vary.We sought to correlate 6-month CRT response assessed by clinical composite score (C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::695c92238be85344506151cd410c66a9
https://doi.org/10.1016/j.hrthm.2021.11.030
https://doi.org/10.1016/j.hrthm.2021.11.030
Autor:
Matthew W. Segar, Nicholas S. Hendren, James B. Young, Lin Zhong, W.H. Wilson Tang, Katherine C. Michelis, Mark H. Drazner, Justin L. Grodin, Ambarish Pandey
Publikováno v:
The American Journal of Cardiology. 164:93-99
Patients with continuous flow destination therapy (DT) left ventricular assist devices (LVAD) comprise a heterogeneous population. We hypothesized that phenotypic clustering of individuals with DT LVADs by their implantation characteristics will be a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3356db748eff5d63979629558ce1be66
https://doi.org/10.1016/j.amjcard.2021.10.028
https://doi.org/10.1016/j.amjcard.2021.10.028
Autor:
James B. Young, Albert E. Raizner
Publikováno v:
Methodist DeBakey Cardiovascular Journal. 18:1-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79373d7f03c29e2bcdc0bd3f1fa5fe8a
https://doi.org/10.14797/mdcvj.1184
https://doi.org/10.14797/mdcvj.1184